Corcept Therapeutics (CORT) Current Leases (2019 - 2026)

Corcept Therapeutics has disclosed Current Leases across 8 years of filings, most recently posting $1.6 million for Q1 2026.

• Current Leases for Q1 2026 came in at $1.6 million, up 65.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (up 65.35% YoY), and the FY2025 annual result was $1.1 million, up 30.76% from the prior year.
• Current Leases came in at $1.6 million for Q1 2026 at Corcept Therapeutics, up from $1.1 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $2.3 million in Q1 2022 to a low of $44000.0 in Q2 2024.
• The 5-year median for Current Leases is $984000.0 (2025), against an average of $927588.2.
• Across the five-year window, Current Leases tumbled 86.88% in 2023 and soared 2211.36% in 2025, its largest moves.
• Corcept Therapeutics' Current Leases stood at $1.1 million in 2022, then sank by 86.79% to $151000.0 in 2023, then jumped by 449.01% to $829000.0 in 2024, then jumped by 30.76% to $1.1 million in 2025, then jumped by 50.09% to $1.6 million in 2026.
• The last three Current Leases figures came in at $1.6 million (Q1 2026), $1.1 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.